The burden and impact of COPD in Asia and Africa
- PMID: 14974740
The burden and impact of COPD in Asia and Africa
Abstract
Chronic obstructive pulmonary disease (COPD) is a leading cause of morbidity and mortality worldwide. The World Health Organization (WHO) estimated that COPD is currently the seventh leading cause of death and disability worldwide, but will rise to the fifth position by 2020. The estimated prevalence of COPD worldwide in 2001 was 1013/100,000 population; it was highest in the Western Pacific Region and lowest in Africa. The mortality from COPD followed the same pattern. The prevalence of smoking is slowly decreasing in the industrialised world and rising in developing countries, especially in Asia and Africa. Cigarette consumption per adult has also decreased in the Americas, remained the same in Europe but increased in all other regions, especially the Western Pacific. Indoor air pollution from combustion of biomass/traditional fuels and coal, previous tuberculous infection, outdoor air pollution and childhood respiratory infections are other important risk factors for COPD in developing countries. The rise in morbidity and mortality from COPD will be most dramatic in Asian and African countries over the next two decades, mostly due to progressive increase in the prevalence of smoking. As developing countries can ill afford the added economic burden of COPD and other smoking-related diseases, there is an urgent need for multi-dimensional actions in reducing the main risk factor of cigarette smoking.
Comment in
-
Management of chronic obstructive pulmonary disease in Asia and Africa.Int J Tuberc Lung Dis. 2004 Feb;8(2):159-70. Int J Tuberc Lung Dis. 2004. PMID: 15139444 Review.
Similar articles
-
Worldwide burden of COPD in high- and low-income countries. Part III. Asia-Pacific studies.Int J Tuberc Lung Dis. 2008 Jul;12(7):713-7. Int J Tuberc Lung Dis. 2008. PMID: 18544193
-
Epidemiology of chronic obstructive pulmonary disease: health effects of air pollution.Respirology. 2006 Sep;11(5):523-32. doi: 10.1111/j.1440-1843.2006.00886.x. Respirology. 2006. PMID: 16916323 Review.
-
Worldwide burden of COPD in high- and low-income countries. Part I. The burden of obstructive lung disease (BOLD) initiative.Int J Tuberc Lung Dis. 2008 Jul;12(7):703-8. Int J Tuberc Lung Dis. 2008. PMID: 18544191
-
Trends in COPD mortality and hospitalizations in countries and regions of Asia-Pacific.Respirology. 2009 Jan;14(1):90-7. doi: 10.1111/j.1440-1843.2008.01415.x. Respirology. 2009. PMID: 19144054
-
Outdoor and indoor air pollution and COPD-related diseases in high- and low-income countries.Int J Tuberc Lung Dis. 2008 Feb;12(2):115-27. Int J Tuberc Lung Dis. 2008. PMID: 18230243 Review.
Cited by
-
Management of NCD in low- and middle-income countries.Glob Heart. 2014 Dec;9(4):431-43. doi: 10.1016/j.gheart.2014.11.003. Glob Heart. 2014. PMID: 25592798 Free PMC article. Review.
-
Burden of Chronic Respiratory Diseases (CRD) in Middle East and North Africa (MENA).World Allergy Organ J. 2011 Jan;4(1 Suppl):S6-8. doi: 10.1097/WOX.0b013e3182093cbb. World Allergy Organ J. 2011. PMID: 23283069 Free PMC article.
-
Impact of chronic respiratory symptoms in a rural area of sub-Saharan Africa: an in-depth qualitative study in the Masindi district of Uganda.Prim Care Respir J. 2013 Sep;22(3):300-5. doi: 10.4104/pcrj.2013.00064. Prim Care Respir J. 2013. PMID: 23817677 Free PMC article.
-
An assessment of health-related quality of life among patients with chronic obstructive pulmonary diseases attending a tertiary care hospital in Bhubaneswar City, India.J Family Med Prim Care. 2018 Sep-Oct;7(5):1047-1053. doi: 10.4103/jfmpc.jfmpc_37_18. J Family Med Prim Care. 2018. PMID: 30598955 Free PMC article.
-
Factors influencing anti-asthmatic generic drug consumption in Morocco: 1999-2010.Springerplus. 2014 Apr 16;3:192. doi: 10.1186/2193-1801-3-192. eCollection 2014. Springerplus. 2014. PMID: 24790832 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials